Aaron Ondrey Insider Profile

4 Followers
Aaron Ondrey, Interim Chief Financial Officer at Mirati Therapeutics, holds 39.46K shares in Mirati Therapeutics (Ticker: MRTX). Most recently, Aaron Ondrey ― shares of Mirati Therapeutics on ― for an estimated value of ―.
tipranks
Aaron  Ondrey

Aaron Ondrey
Mirati Therapeutics (MRTX)
Interim Chief Financial Officer

Not Ranked
Aaron Ondrey has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Aaron Ondrey does not currently own shares as a corporate insider.
A breakdown of Aaron Ondrey's holdings

Insider Roles

Aaron Ondrey does not currently hold a role as a corporate insider.
Roles that Aaron Ondrey holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Aaron Ondrey

Aaron Ondrey's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MRTX
Mirati Therapeutics
$2.32M
MRTX
is no longer traded
Aaron Ondrey has not reported any informative transactions for MRTX, therefore, performance cannot be measured.
List of latest transactions for each holding click on a transaction to see Aaron Ondrey's performance on stock

Aaron Ondrey insider profile FAQ

What is the percentage of profitable transactions made by Aaron Ondrey?
The percentage of profitable transactions made by Aaron Ondrey is ―.
    What is the average return per transaction made by Aaron Ondrey?
    The average return per transaction made by Aaron Ondrey is ―.
      What stocks does Aaron Ondrey hold?
      Aaron Ondrey holds: MRTX stocks.
        What was Aaron Ondrey’s latest transaction?
        Aaron Ondrey latest transaction was an Uninformative Buy of ―.
          What was Aaron Ondrey's most profitable transaction?
          Aaron Ondrey’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Aaron Ondrey's role in Mirati Therapeutics?
            Aaron Ondrey's role in Mirati Therapeutics is Interim Chief Financial Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.